Human insulin/EDTA/Citrate/Magnesium sulfate (Biodel)

N/A

Report date: 2022/11/25 17:25:14

Base Information

Drug NameHuman insulin/EDTA/Citrate/Magnesium sulfate (Biodel)
Drug Alias NameHuman insulin/Citrate/Magnesium sulfate/EDTAHuman insulin/Citrate/EDTA/Magnesium sulfateBIOD-123
ClassificationBiologics
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlbireo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiodel Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A